POSC258 Acceptance of Progression-Free Survival 2 (PFS2) By EU5 and Canadian Health Authorities for Cancer Drug Reimbursement
| Autor: | Rizzello, E, Leopaldi, C, Massó, B, Vidalis, A, Kachouh, P, Bechara, A, Milnes, J |
|---|---|
| Zdroj: | In Value in Health January 2022 25(1) Supplement:S184-S184 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect